136 related articles for article (PubMed ID: 17093347)
1. Symptom exacerbation and adherence to antiretroviral therapy during the menstrual cycle: a pilot study.
Patel PN; Grimes RM
Infect Dis Obstet Gynecol; 2006; 2006():14869. PubMed ID: 17093347
[TBL] [Abstract][Full Text] [Related]
2. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.
Ammassari A; Murri R; Pezzotti P; Trotta MP; Ravasio L; De Longis P; Lo Caputo S; Narciso P; Pauluzzi S; Carosi G; Nappa S; Piano P; Izzo CM; Lichtner M; Rezza G; Monforte A; Ippolito G; d'Arminio Moroni M; Wu AW; Antinori A;
J Acquir Immune Defic Syndr; 2001 Dec; 28(5):445-9. PubMed ID: 11744832
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.
Silverberg MJ; Gore ME; French AL; Gandhi M; Glesby MJ; Kovacs A; Wilson TE; Young MA; Gange SJ
Clin Infect Dis; 2004 Sep; 39(5):717-24. PubMed ID: 15356788
[TBL] [Abstract][Full Text] [Related]
4. Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART.
Guaraldi G; Murri R; Orlando G; Orlandi E; Sterrantino G; Borderi M; Grosso C; Cattelan AM; Nardini G; Beghetto B; Antinori A; Esposito R; Wu AW
HIV Clin Trials; 2003; 4(2):99-106. PubMed ID: 12671777
[TBL] [Abstract][Full Text] [Related]
5. Menopausal symptoms are associated with non-adherence to highly active antiretroviral therapy in human immunodeficiency virus-infected middle-aged women.
Cutimanco-Pacheco V; Arriola-Montenegro J; Mezones-Holguin E; Niño-Garcia R; Bonifacio-Morales N; Lucchetti-Rodríguez A; Ticona-Chávez E; Blümel JE; Pérez-López FR; Chedraui P
Climacteric; 2020 Jun; 23(3):229-236. PubMed ID: 31809600
[No Abstract] [Full Text] [Related]
6. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
Stone VE; Jordan J; Tolson J; Miller R; Pilon T
J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
[TBL] [Abstract][Full Text] [Related]
7. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
Zorrilla CD; Santiago LE; Knubson D; Liberatore K; Estronza G; Colón O; Acevedo M
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
[TBL] [Abstract][Full Text] [Related]
8. Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals.
Trotta MP; Ammassari A; Murri R; Marconi P; Zaccarelli M; Cozzi-Lepri A; Acinapura R; Abrescia N; De Longis P; Tozzi V; Scalzini A; Vullo V; Boumis E; Nasta P; Monforte Ad; Antinori A;
AIDS Patient Care STDS; 2008 Apr; 22(4):291-9. PubMed ID: 18422461
[TBL] [Abstract][Full Text] [Related]
9. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
[TBL] [Abstract][Full Text] [Related]
10. Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: a qualitative study.
Sidat M; Fairley C; Grierson J
AIDS Patient Care STDS; 2007 Jul; 21(7):509-20. PubMed ID: 17651032
[TBL] [Abstract][Full Text] [Related]
11. Qualitative and quantitative assessments of HAART adherence of substance-abusing women.
Powell-Cope GM; White J; Henkelman EJ; Turner BJ
AIDS Care; 2003 Apr; 15(2):239-49. PubMed ID: 12856345
[TBL] [Abstract][Full Text] [Related]
12. Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.
Merenstein D; Schneider MF; Cox C; Schwartz R; Weber K; Robison E; Gandhi M; Richardson J; Plankey MW
AIDS Patient Care STDS; 2009 Apr; 23(4):289-96. PubMed ID: 19243274
[TBL] [Abstract][Full Text] [Related]
13. Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study.
Nakimuli-Mpungu E; Mutamba B; Othengo M; Musisi S
Afr Health Sci; 2009 Aug; 9 Suppl 1(Suppl 1):S2-7. PubMed ID: 20589156
[TBL] [Abstract][Full Text] [Related]
14. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients.
Maggiolo F; Ripamonti D; Arici C; Gregis G; Quinzan G; Camacho GA; Ravasio L; Suter F
HIV Clin Trials; 2002; 3(5):371-8. PubMed ID: 12407486
[TBL] [Abstract][Full Text] [Related]
15. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
17. Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings.
Venkatesh KK; Srikrishnan AK; Mayer KH; Kumarasamy N; Raminani S; Thamburaj E; Prasad L; Triche EW; Solomon S; Safren SA
AIDS Patient Care STDS; 2010 Dec; 24(12):795-803. PubMed ID: 21091232
[TBL] [Abstract][Full Text] [Related]
18. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
[TBL] [Abstract][Full Text] [Related]
19. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.
Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW
AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079
[TBL] [Abstract][Full Text] [Related]
20. Do women with HIV/AIDS on anti-retroviral therapy have a lower incidence of symptoms associated with menstrual dysfunction?
Tempest N; Edirisinghe DN; Lane S; Hapangama DK
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():137-142. PubMed ID: 34492608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
